- TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System
- TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart System
- TransMedics Appoints Stephanie Lovell to Board of Directors
- TransMedics Reports Fourth Quarter and Full Year 2020 Financial Results
- TransMedics Announces Scheduling of OCS Heart FDA Advisory Committee Meeting
- TransMedics to Present at the Cowen 41st Annual Healthcare Conference
- TransMedics to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021
Transmedics Group Inc (TMDX:NMQ) closed at 28.61, 148.57% above the 52 week low of 11.51 set on Oct 30, 2020.
11.51Oct 30 202049.50Mar 22 2021
Markit short selling activity
|Market cap||869.27m USD|
|EPS (TTM)||-1.20 |
Data delayed at least 15 minutes, as of Apr 12 2021 21:00 BST.